Molecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.
Dr. Alberto Lima Hospital of Clinics, Macapá, Amapá, Brazil.
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):157-162. doi: 10.31557/APJCP.2023.24.1.157.
The polymorphisms Arg72Pro in the TP53 gene (rs1042522) and Ile655Val in the HER2 gene (rs1136201) have been related to susceptibility to several types of cancer. Different studies show the association of these polymorphisms with breast cancer, so our aim in this study was to investigate whether the Arg72Pro and Ile655Val polymorphisms have any influence on the risk of developing breast cancer in women from the city of Macapá, Amapá, located in the brazilian amazon region.
We then analyzed 80 DNA samples from women with breast cancer and 83 DNA samples from women without the disease, by the Restriction Fragment Length Polymorphism - Polymerase Chain Reaction (PCR-RFLP) technique. The genotype frequencies for rs1042522 were Ar/Arg 23.7%, Arg/Pro 47.5% and Pro/Pro 28.5% in patients and in controls Ar/Arg 69.8%, Arg/Pro 19.2% and Pro/Pro 10.8%. For the HER-2 gene the frequency of Ile/Ile, Ile/Val and Val/Val genotypes was 82.5%, 17.5% and 0% in the patients and 75.9%, 20.4% and 3.6% in the controls. The presence of at least one altered allele in rs1042522 and rs1136201 polymorphisms was found in 91.25% of patient samples.
This study found a significant association between the Arg/Pro and Pro/Pro genotypes in the TP53 gene and the Ile/Val genotype in the HER-2 gene and breast cancer risk, however, we emphasize that more studies need to be carried out in the investigated population to consolidate our results.
TP53 基因中的 Arg72Pro 多态性(rs1042522)和 HER2 基因中的 Ile655Val 多态性(rs1136201)与多种癌症的易感性有关。不同的研究表明这些多态性与乳腺癌有关,因此我们在这项研究中的目的是调查 TP53 基因中的 Arg72Pro 和 HER2 基因中的 Ile655Val 多态性是否会影响巴西亚马孙地区马卡帕市女性患乳腺癌的风险。
我们随后通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术分析了 80 例乳腺癌患者和 83 例无该病的女性的 80 份 DNA 样本。rs1042522 的基因型频率在患者中为 Ar/Arg 23.7%、Arg/Pro 47.5%和 Pro/Pro 28.5%,在对照组中为 Ar/Arg 69.8%、Arg/Pro 19.2%和 Pro/Pro 10.8%。对于 HER-2 基因,Ile/Ile、Ile/Val 和 Val/Val 基因型的频率在患者中分别为 82.5%、17.5%和 0%,在对照组中分别为 75.9%、20.4%和 3.6%。rs1042522 和 rs1136201 多态性中至少存在一个改变等位基因的患者样本占 91.25%。
本研究发现 TP53 基因中的 Arg/Pro 和 Pro/Pro 基因型与 HER-2 基因中的 Ile/Val 基因型与乳腺癌风险之间存在显著关联,但我们强调需要在研究人群中进行更多研究以证实我们的结果。